Nephroprotective Effect of Withania somnifera: A Dose-Dependent Study

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamilnadu, India.
Renal Failure (Impact Factor: 0.94). 10/2009; 31(9):814-21. DOI: 10.3109/08860220903150320
Source: PubMed


In the present study, we investigated the protective effect of Withania somnifera, an indigenous medicinal herb used in ayurvedic traditional systems for more than 3000 years in India, on gentamicin (GEN)-induced nephrotoxicity. The root extract of three different doses of W. somnifera (viz., 250, 500, and 750 mg/kg) was administered orally to rats for 14 days before GEN treatment and thereafter concurrently with GEN (100 mg/kg) for 8 days. Nephrotoxicity was evident in GEN-treated rats by significant increase in kidney weight, urea, creatinine, urinary protein, and glucose, and significant reduction in body weights and potassium, which was histopathologically confirmed by tubular necrosis. In contrast W. somnifera (500 mg/kg) significantly reversed these changes as evidenced microscopically when compared to other two doses of W. somnifera (250 and 750 mg/kg), and there were no significant changes in the levels of sodium in the experimental animals compared to control. Thus, our results suggested the nephroprotective effect of Withania somnifera, which could be by enhancing antioxidant activity with natural antioxidants and scavenging the free radicals.

Download full-text


Available from: Perumal Subramanian, Apr 16, 2015
  • Source
    • "Stojiljkovic et al. (2008) and Patil et al. (2010) r e p o r t e d t h a t t o x i c d o s e s o f g e n t a mic i n c a us e s impairment of renal microcirculation and glomerular hemodynamics thus, decreases glomerular f iltration rate and thereb y increases serum urea and creatinine levels. Maldonado et al. (2003) and Jeyanthi et al. (2009) reported that gentamicine-induced toxicity may cause excessive for mation of ROS (reactive oxygen species) such as O 2 , OH and H 2 O 2 that stimulate mesangial cells contraction which result in decreased GFR and increased serum urea and creatinine levels. Ghasi et a l. ( 2 0 1 1 ) r e po r t e d t h a t B r y o p h yl l u m pinnatum p la n t s i n c r ea s e d B UN and d ec r ease d creatinine level in serum of the studied rabbits and the chemical analysis o f t his p lant showed t hat it ha d alkaloidal fraction that increased BUN. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Fumaria officinalis is one of the herbal medicines used in Iran extensively. There are many useful properties recognized for this plant, but there is no information about its side effects specially in long term and at high doses. The objective of the present study was to investigate the effects of Fumaria officinalis hydroalcoholic extract on the BUN and serum creatinine concentrations as indicators of kidney function. Thirty adult male New Zealand rabbits were chosen randomly and were divided into three groups of ten. The control group did not receive any drug. Two experimental groups received 200mg/kg and 400mg/kg of Fumaria officinalis extract for 28 days (groups two and three, respectively). On day-28 blood samples were taken, BUN and creatinine concentrations were assayed by enzymatic methods. In the present study the Fumaria officinalis hydroalcoholic extract administration increased BUN and serum creatinine concentrations significantly in group1, but BUN decreased and serum creatinine increased significantly in group 2(P<0.05). It was concluded that high doses of hydroalcoholic extract of Fumaria officinalis can have detrimental effects on renal and hepatic function but in medium doses cause renal failure.
    Medicinal Plants - International Journal of Phytomedicines and Related Industries 01/2013; 5(3):155. DOI:10.5958/j.0975-6892.5.3.024
  • Source
    • "Gentamicin-induced weight loss observed in the present study is in line with previous reports (Harlalka et al., 2007; Jeyanthi and Subramanian, 2009; Lakshmi and Sudhakar, 2010) and may be related to direct renal tubules injury and/or increased catabolism. Injury of the renal tubules leads to subsequent loss of the tubular cells that take part in renal water reabsorption. "
    [Show abstract] [Hide abstract]
    ABSTRACT: ETHNOPHARMACOLOGICAL RELEVANCE: Euclea divinorum Hierns (Ebenaceae) is used in Ethiopian folklore medicine to treat scabies, inflammation of the skin, eczema, abdominal pain, gonorrhea, and kidney problems. However, the claim has not been scientifically validated. AIM OF THE STUDY: To assess the renoprotective effects of the crude extract and solvent fractions of E. divinorum leaves against gentamicin-induced nephrotoxicity in rats. MATERIALS AND METHOD: Rats of either sex were divided into seven experimental groups, each comprising six animals. Group I served as control and given vehicle (Tween 80, 2%, v/v in water) and Group II were treated with gentamicin intraperitoneally (100mg/kg/day) for eight days. Group III-V received crude extract at three different doses 100mg/kg, 150mg/kg and 200mg/kg, respectively. Group VI received 100mg/kg of the methanolic fraction and Group VII 100mg/kg of the aqueous fraction. The extract was administered orally two days before and eight days concomitantly with gentamicin. Following treatment, blood and renal tissue were used to assess creatinine, blood urea nitrogen (BUN), malonaldehyde (MDA), antioxidant enzymes and tubular necrosis using recommended procedures. In addition, free radical scavenging activity was determined using in vitro methods. RESULTS: Gentamicin significantly increased serum creatinine and BUN, MDA and tubular necrosis in rats. It also decreased activity of catalase and superoxide dismutase as well as levels of gluthatione. Pre- and co-treatment with the crude extract and solvent fractions of E. divinorum leaves reversed gentamicin-induced alterations as evidenced by a decrease in tubular necrosis, serum and oxidant markers as well as by an increase in antioxidant molecules. Effect was found to decrease with dose when the crude extract was used and maximum protection was conferred by the 100mg/kg of the methanolic fraction in both in vivo and in vitro studies. CONCLUSIONS: E. divinorum reversed gentamicin-nduced nephrotoxicity, probably via its antioxidant activity. The fact that the methanol fraction conferred maximum protection suggests that semi polar antioxidant principles might be responsible for the observed effect.
    Journal of ethnopharmacology 12/2012; 145(3). DOI:10.1016/j.jep.2012.12.006 · 3.00 Impact Factor
  • Source
    • "Although some aminoglycosides (e.g. mycins) have been reported to be toxic to mammalian cells (Guthrie, 2008; Martinez-Salgado et al., 2007; Rizzi and Hirose, 2007), this can be reduced through careful management (Murakami et al., 2008; Pannu and Nadim, 2008) and/or improved formulations that incorporate, for example, low-molecular weight proteins (Tugcu et al., 2006) and/or other compounds ( Jeyanthi and Subramanian, 2009; Nagai and Takano, 2010). Moreover, with current technologies , it should be possible to synthesize analogues with optimum bioavailability and parasite-specificity (supported by chemical, structural and in silico docking studies) but negligible toxicity to host tissues. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cryptosporidium is an important genus of parasitic protozoa of humans and other vertebrates and is a major cause of intestinal disease globally. Unlike many common causes of infectious enteritis, there are no widely available, effective vaccine or drug-based intervention strategies for Cryptosporidium, and control is focused mainly on prevention. This approach is particularly deficient for infections of severely immunocompromised and/or suppressed, the elderly or malnourished people. However, cryptosporidiosis also presents a significant burden on immunocompetent individuals, and can, for example have lasting effects on the physical and mental development of children infected at an early age. In the last few decades, our understanding of Cryptosporidium has expanded significantly in numerous areas, including the parasite life-cycle, the processes of excystation, cellular invasion and reproduction, and the interplay between parasite and host. Nonetheless, despite extensive research, many aspects of the biology of Cryptosporidium remain unknown, and treatment and control are challenging. Here, we review the current state of knowledge of Cryptosporidium, with a focus on major advances arising from the recently completed genome sequences of the two species of greatest relevance in humans, namely Cryptosporidium hominis and Cryptosporidium parvum. In addition, we discuss the potential of next-generation sequencing technologies, new advances in in silico analyses and progress in in vitro culturing systems to bridge these gaps and to lead toward effective treatment and control of cryptosporidiosis.
    Advances in Parasitology 01/2011; 77:141-73. DOI:10.1016/B978-0-12-391429-3.00007-1 · 6.23 Impact Factor
Show more